Fritextsökning
Innehållstyper
-
Merck slutar sälja rotavirusvaccin i Västafrika
I ett upprop uppmanar organisationen Care2 läkemedelsbolaget Merck att ändra sitt beslut att upphöra med prisnedsatt rotavirusvaccin till barn i Västafrika.
-
Almost 150 will leave Coloplast
The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.
-
High hopes for future partnering - the solution for struggling fairs
Business fairs are struggling but the concept of partnering is hotter than ever. By using social media, participants can prepare themselves for the perfect meeting.
-
Athera signs production partnership
The companys novel cardiovascular product will be manufactured in Germany.
-
Happy exhibitors!
There were fewer vistors this year but most exhibitors are content.
-
First ever study of human stem cell treatment
The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.
-
Stockholm-Uppsala life science cluster in brief
Stockholm-Uppsala evolves around the research at Karolinska Institutet and Uppsala University. Typical areas of research are protein research, neuroscience and cancer.
-
Trio goes in for high tech medicines
The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.
-
One-step cleaning system for use in clean rooms
The Micronswep cleaning system from Berendsen is a single action cleaning system developed for use in clean rooms.
-
Go ahead for leg wound study
Tripep starts a phase II-study of their wound healing joint venture project.
-
Ny chef på Bactiguard
I augusti tillträder Gabriella Björknert Caracciolo som ny CFO samt vice vd på Bactiguard.
-
Medtech giant separates
Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.
-
Vinnova ger stöd till precisionsmedicin – här är projekten som får anslag
Vinnova anslår totalt 323 miljoner kronor i en stor satsning på precisionsmedicin.
-
Vaccinkandidat används i pågående utbrott
Ebolavaccin under utveckling skickas till Demokratiska republiken Kongo.
-
Biogaia's advance goes on
In December Biogaia reached China and North America. Now, the Swedish probiotic company has entered the Mexican market.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
"Individer som har modet att engagera sig måste belönas"
Sara Gunnerås, director business and finance, SwedenBio kommenterar det femte förslaget om Skärp målsättningen för deltagande i EU:s ramprogram.
-
Studie: Ny typ av cellterapi kan läka skador på hjärta efter infarkt
I en ny studie har forskare från bland annat Karolinska institutet, Astra Zeneca och Technical University of Munich identifierat en ny typ av cellterapi som har...
-
Teams up with leading dermatologist
Tripep has signed a letter of intent with a major Japanese specialty pharma company to bring their wound healing treatment to a big market.
-
Blood type decide resistance to HIV
A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.
-
Vattenfall is firing with biomass
Vattenfall will provide Denmark with electricity by means of biomass.
-
Danisco first with green emulsifier
A new sustainable emulsifier from Danisco meets the increasing consumer demand for ethically correct consumer goods.
-
New automated solution for flexible molecular assays
The fully integrated Qiasymphony is a new automated platform for flexible molecular testing.
-
Fat cells' reaction differs with body weight
The fat cells of overweight people may react differently to dietary changes than in their lean peers, according to a pioneering study from the Dutch organizatio...
BREAKING